Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Enliven Therapeutics Inc | 5,160,975 | 3,835,975 | -1,325,000 | $71.43M | $67.47M | 15.11% | -$3.95M |
| Entrada Therapeutics, Inc.(TRDA) | 4,408,379 | 4,408,379 | 0 | $66.52M | $62.47M | 13.99% | -$4.06M |
| Dianthus Therapeutics, Inc.(DNTH) | 1,472,264 | 1,242,029 | -230,235 | $15.31M | $37.26M | 8.34% | +$21.95M |
| Merus N V | 521,531 | 548,825 | +27,294 | $14.34M | $24.71M | 5.53% | +$10.37M |
| Celldex Therapeutics, Inc.(CLDX) | 497,270 | 497,270 | 0 | $19.72M | $20.87M | 4.67% | +$1.15M |
| Praxis Precision Medicines, Inc.(PRAX) | 0 | 340,000 | +340,000 | $0 | $20.75M | 4.65% | +$20.75M |
| Viking Therapeutics, Inc.(VKTX) | 585,000 | 237,560 | -347,440 | $10.89M | $19.48M | 4.36% | +$8.59M |
| Pharvaris N V COM | 797,600 | 797,600 | 0 | $22.37M | $18.43M | 4.13% | -$3.94M |
| Biohaven Ltd.(BHVN) | 399,972 | 319,972 | -80,000 | $17.12M | $17.50M | 3.92% | +$380.5K |
| Avidity Biosciences Inc | 665,555 | 665,555 | 0 | $6.02M | $16.98M | 3.80% | +$10.96M |
| Tyra Biosciences, Inc.(TYRA) | 554,979 | 939,298 | +384,319 | $7.69M | $15.40M | 3.45% | +$7.72M |
| Vor Biopharma Inc.(VOR) | 6,361,723 | 6,361,723 | 0 | $14.31M | $15.08M | 3.38% | +$763.4K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 302,630 | 282,313 | -20,317 | $18.28M | $14.18M | 3.18% | -$4.10M |
| Centessa Pharmaceuticals PlcADS | 0 | 1,245,000 | +1,245,000 | $0 | $14.07M | 3.15% | +$14.07M |
| Viridian Therapeutics, Inc.(VRDN) | 586,595 | 736,595 | +150,000 | $12.78M | $12.90M | 2.89% | +$121.7K |
| Silence Therapeutics plcADS(SLN) | 0 | 476,200 | +476,200 | $0 | $10.29M | 2.30% | +$10.29M |
| Anaptysbio Inc | 357,733 | 357,733 | 0 | $7.66M | $8.06M | 1.80% | +$393.5K |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 490,000 | 490,000 | 0 | $7.42M | $7.72M | 1.73% | +$298.9K |
| Adverum Biotechnologies Inc | 0 | 541,666 | +541,666 | $0 | $7.66M | 1.71% | +$7.66M |
| Rallybio Corporation(RLYB) | 3,630,724 | 3,630,724 | 0 | $8.68M | $6.72M | 1.50% | -$1.96M |
| GH Research PLC(GHRS) | 404,404 | 572,665 | +168,261 | $2.35M | $6.10M | 1.37% | +$3.76M |
| Scpharmaceuticals Inc | 1,200,647 | 1,200,647 | 0 | $7.53M | $6.03M | 1.35% | -$1.50M |
| Mersana Therapeutics Inc | 1,305,000 | 1,305,000 | 0 | $3.03M | $5.85M | 1.31% | +$2.82M |
| Cogent Biosciences, Inc.(COGT) | 790,440 | 790,440 | 0 | $4.65M | $5.31M | 1.19% | +$664.0K |
| Q32 Bio Inc.(QTTB) | 0 | 251,994 | +251,994 | $0 | $4.29M | 0.96% | +$4.29M |
| Cidara Therapeutics Inc | 1,134,511 | 1,134,511 | 0 | $900.8K | $1.04M | 0.23% | +$142.9K |
| Disc Medicine, Inc.(IRON) | 294,221 | 0 | -294,221 | $16.99M | $0 | — | -$16.99M |
| Homology Medicines Inc | 4,535,919 | 0 | -4,535,919 | $2.76M | $0 | — | -$2.76M |
| Mirati Therapeutics Inc | 192,500 | 0 | -192,500 | $11.31M | $0 | — | -$11.31M |
| Spruce Biosciences Inc | 2,364,000 | 0 | -2,364,000 | $6.93M | $0 | — | -$6.93M |